- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope National Medical Center /ID# 273132 Duarte, California, United States
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911 Irvine, California, United States
- Colorado Blood Cancer Institute /ID# 273129 Denver, Colorado, United States
- Moffitt Cancer Center /ID# 272628 Tampa, Florida, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,021 public trials
2,029 recruiting studies
Lymphoproliferative Disorders trial results
Recruiting
Evaluation of Pediatric eCART Implementation
NCT06771830
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- American Family Children's Hospital Madison, Wisconsin, United States
NCT07205315
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
- Locations
-
- Zhengzhou Yihe Hospital Zhengzhou, Henan, China
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
NCT06855121
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
- Locations
-
- Sørlandet Hospital - Arendal Arendal, Norway
- Ålesund hospital, Department of hematology Ålesund, Norway
- Haukeland University Hospital Bergen, Norway
- Bodø Hospital Bodø, Norway
NCT07555938
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- City of Hope - Lennar Foundation Cancer Center Irvine, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Novant Health Cancer Institute Charlotte, North Carolina, United States
Recruiting
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
NCT07620314
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT07715630
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Kunming, Yunnan, China
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- USA Mitchell Cancer Institute ( Site 0014) Mobile, Alabama, United States
- Banner MD Anderson Cancer Center ( Site 0059) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051) Phoenix, Arizona, United States
- Arizona Oncology Associates - NAHOA ( Site 8007) Prescott, Arizona, United States
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT07409428
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Baoding NO.1 Central Hospital Baoding, China
- Beijing GoBroad Hospital Beijing, China
- BEIJING TONGREN HOSPITAL, Capital Medical University Beijing, China
- Conditions
- B-Cell Non-Hodgkins Lymphoma, Cytokine Release Syndrome, Disease Attributes, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States